|
G. Steven Burrill is CEO of Burrill & Company, a San Francisco-based life sciences firm with principal activities in Venture Capital, Merchant Banking and Media, and has been involved in the growth and prosperity of the biotechnology industry for over 35 years. An early pioneer, Mr. Burrill is one of the original architects of the industry and one of its most avid and sustained developers. Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the biotechnology/life sciences/high technology/manufacturing industries worldwide. In 2002, Mr. Burrill was recognized as the biotech investment visionary by the prestigious Scientific American magazine (The Scientific American 50). | 